Explain why commercialization readiness begins much sooner than executives think. Identify early operational ...

Identify early operational decisions—product handling requirements, product configuration, transportation strategies, temperature management requirements, and supply chain design—that affect ...

As patient expectations continue to evolve, brick-and-mortar pharmacy’s path forward lies in combining trusted, face-to-face ...

Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet ...

For many CGT manufacturers, Europe is part of the long-term commercialization plan. However, planning for European expansion often begins later than it should. Regulatory requirements, market access ...

In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and ...

DSCSA compliance is no longer a live question for most trading partners, but two new work streams, the shift to a 12-digit ...

The EU's pharma reform makes market protection more conditional. Here is how US drugmakers, especially startups, can adapt and use IP to complement it. The European Union's (EU) pharmaceutical reform ...

Valerie Bandy of Tecsys on where 340B rebate mechanics threaten pharmacy purchasing, and how stakeholders can prevent disruption. In the third and final installment of Pharmaceutical Commerce’s video ...

Dynamic offer and cap governance can curb disproportionate spend from high-cost, low-persistence claim outliers without sacrificing volume, but requires continuous monitoring and iterative design ...

In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk ...